These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 37876835)

  • 1. CD4+ T cell-derived IL-22 enhances liver metastasis by promoting angiogenesis.
    Zhang T; Wahib R; Zazara DE; Lücke J; Shiri AM; Kempski J; Zhao L; Agalioti T; Machicote AP; Giannou O; Belios I; Jia R; Zhang S; Tintelnot J; Seese H; Grass JK; Mercanoglu B; Stern L; Scognamiglio P; Fard-Aghaie M; Seeger P; Wakker J; Kemper M; Brunswig B; Duprée A; Lykoudis PM; Pikouli A; Giorgakis E; Stringa P; Lausada N; Gentilini MV; Gondolesi GE; Bachmann K; Busch P; Grotelüschen R; Maroulis IC; Arck PC; Nakano R; Thomson AW; Ghadban T; Tachezy M; Melling N; Achilles EG; Puelles VG; Nickel F; Hackert T; Mann O; Izbicki JR; Li J; Gagliani N; Huber S; Giannou AD
    Oncoimmunology; 2023; 12(1):2269634. PubMed ID: 37876835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue resident iNKT17 cells facilitate cancer cell extravasation in liver metastasis via interleukin-22.
    Giannou AD; Kempski J; Shiri AM; Lücke J; Zhang T; Zhao L; Zazara DE; Cortesi F; Riecken K; Amezcua Vesely MC; Low JS; Xu H; Kaffe E; Garcia-Perez L; Agalioti T; Yamada Y; Jungraithmayr W; Zigmond E; Karstens KF; Steglich B; Wagner J; Konczalla L; Carambia A; Schulze K; von Felden J; May P; Briukhovetska D; Bedke T; Brockmann L; Starzonek S; Lange T; Koch C; Riethdorf S; Pelczar P; Böttcher M; Sabihi M; Huber FJ; Reeh M; Grass JK; Wahib R; Seese H; Stüben BO; Fard-Aghaie M; Duprée A; Scognamiglio P; Plitzko G; Meiners J; Soukou S; Wittek A; Manthey C; Maroulis IC; Arck PC; Perez D; Gao B; Zarogiannis SG; Strowig T; Pasqualini R; Arap W; Gosálvez JS; Kobold S; Prinz I; Guse AH; Tachezy M; Ghadban T; Heumann A; Li J; Melling N; Mann O; Izbicki JR; Pantel K; Schumacher U; Lohse AW; Flavell RA; Gagliani N; Huber S
    Immunity; 2023 Jan; 56(1):125-142.e12. PubMed ID: 36630911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of Th22, Th17 and CD4
    Doulabi H; Rastin M; Shabahangh H; Maddah G; Abdollahi A; Nosratabadi R; Esmaeili SA; Mahmoudi M
    Biomed Pharmacother; 2018 Jul; 103():1101-1106. PubMed ID: 29710675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-22 produced by Th22 cells aggravates atherosclerosis development in ApoE
    Shi L; Ji Q; Liu L; Shi Y; Lu Z; Ye J; Zeng T; Xue Y; Yang Z; Liu Y; Lu J; Huang X; Qin Q; Li T; Lin YZ
    J Cell Mol Med; 2020 Mar; 24(5):3064-3078. PubMed ID: 32022386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of IL-22-producing T helper 22 cells by RPE cells via PD-L1/PD-1 interactions.
    Sugita S; Kawazoe Y; Imai A; Usui Y; Takahashi M; Mochizuki M
    Invest Ophthalmol Vis Sci; 2013 Oct; 54(10):6926-33. PubMed ID: 24065812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of IL-22- and TNF-α-producing Th22 cells in uveitis patients with Behcet's disease.
    Sugita S; Kawazoe Y; Imai A; Kawaguchi T; Horie S; Keino H; Takahashi M; Mochizuki M
    J Immunol; 2013 Jun; 190(11):5799-808. PubMed ID: 23630362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-22-producing Th22 cells play a protective role in CVB3-induced chronic myocarditis and dilated cardiomyopathy by inhibiting myocardial fibrosis.
    Guo Y; Wu W; Cen Z; Li X; Kong Q; Zhou Q
    Virol J; 2014 Dec; 11():230. PubMed ID: 25547181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoregulation therapy changes the frequency of interleukin (IL)-22+ CD4+ T cells in systemic lupus erythematosus patients.
    Zhao L; Ma H; Jiang Z; Jiang Y; Ma N
    Clin Exp Immunol; 2014 Jul; 177(1):212-8. PubMed ID: 24635166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased circulating Th22 and Th17 cells are associated with tumor progression and patient survival in human gastric cancer.
    Liu T; Peng L; Yu P; Zhao Y; Shi Y; Mao X; Chen W; Cheng P; Wang T; Chen N; Zhang J; Liu X; Li N; Guo G; Tong W; Zhuang Y; Zou Q
    J Clin Immunol; 2012 Dec; 32(6):1332-9. PubMed ID: 22760549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of SHP-2 activity in CD4+ T cells promotes melanoma progression and metastasis.
    Zhang T; Guo W; Yang Y; Liu W; Guo L; Gu Y; Shu Y; Wang L; Wu X; Hua Z; Ke Y; Sun Y; Shen Y; Xu Q
    Sci Rep; 2013 Oct; 3():2845. PubMed ID: 24088816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical features of imbalance between Th1 and Th22 cells and its association with disease progression in patients with liver cirrhosis].
    Wu HQ; Zhao JJ; Li HW; Zhang Z
    Zhonghua Gan Zang Bing Za Zhi; 2017 Oct; 25(10):738-744. PubMed ID: 29108201
    [No Abstract]   [Full Text] [Related]  

  • 12. Th22 Cells Contribution in Immunopathogenesis of Rheumatic Diseases.
    Azizi G; Simhag A; El Rouby NM; Mirshafiey A
    Iran J Allergy Asthma Immunol; 2015 Jun; 14(3):246-54. PubMed ID: 26546892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA 15a/16-1 suppresses aryl hydrocarbon receptor-dependent interleukin-22 secretion in CD4
    Lu Z; Liu J; Liu X; Huang E; Yang J; Qian J; Zhang D; Liu R; Chu Y
    Hepatology; 2018 Mar; 67(3):1027-1040. PubMed ID: 29023933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-22 secreting CD4+ T cells in the patients with neuromyelitis optica and multiple sclerosis.
    Xu W; Li R; Dai Y; Wu A; Wang H; Cheng C; Qiu W; Lu Z; Zhong X; Shu Y; Kermode AG; Hu X
    J Neuroimmunol; 2013 Aug; 261(1-2):87-91. PubMed ID: 23726764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Th22 Cells Promote Osteoclast Differentiation
    Miyazaki Y; Nakayamada S; Kubo S; Nakano K; Iwata S; Miyagawa I; Ma X; Trimova G; Sakata K; Tanaka Y
    Front Immunol; 2018; 9():2901. PubMed ID: 30619268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Imbalance between Foxp3
    Liang M; Liwen Z; Yun Z; Yanbo D; Jianping C
    J Immunol Res; 2018; 2018():3753081. PubMed ID: 30050955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased intratumoral interleukin 22 levels and frequencies of interleukin 22-producing CD4+ T cells correlate with pancreatic cancer progression.
    Xu X; Tang Y; Guo S; Zhang Y; Tian Y; Ni B; Wang H
    Pancreas; 2014 Apr; 43(3):470-7. PubMed ID: 24622082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The balance between IL-17 and IL-22 produced by liver-infiltrating T-helper cells critically controls NASH development in mice.
    Rolla S; Alchera E; Imarisio C; Bardina V; Valente G; Cappello P; Mombello C; Follenzi A; Novelli F; Carini R
    Clin Sci (Lond); 2016 Feb; 130(3):193-203. PubMed ID: 26558403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-TNF Therapy Induces CD4+ T-Cell Production of IL-22 and Promotes Epithelial Repairs in Patients With Crohn's Disease.
    Fang L; Pang Z; Shu W; Wu W; Sun M; Cong Y; Liu Z
    Inflamm Bowel Dis; 2018 Jul; 24(8):1733-1744. PubMed ID: 29718341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Th22 response induced by Mycobacterium tuberculosis strains is closely related to severity of pulmonary lesions and bacillary load in patients with multi-drug-resistant tuberculosis.
    Imperiale BR; García A; Minotti A; González Montaner P; Moracho L; Morcillo NS; Palmero DJ; Sasiain MDC; de la Barrera S
    Clin Exp Immunol; 2021 Feb; 203(2):267-280. PubMed ID: 33128773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.